156 related articles for article (PubMed ID: 24457639)
1. Animal models of schizophrenia: developmental preparation in rats.
Ratajczak P; Wozniak A; Nowakowska E
Acta Neurobiol Exp (Wars); 2013; 73(4):472-84. PubMed ID: 24457639
[TBL] [Abstract][Full Text] [Related]
2. Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia.
Lodge DJ; Grace AA
Behav Brain Res; 2009 Dec; 204(2):306-12. PubMed ID: 19716984
[TBL] [Abstract][Full Text] [Related]
3. Memory deficits with intact cognitive control in the methylazoxymethanol acetate (MAM) exposure model of neurodevelopmental insult.
O'Reilly KC; Perica MI; Fenton AA
Neurobiol Learn Mem; 2016 Oct; 134 Pt B(Pt B):294-303. PubMed ID: 27485950
[TBL] [Abstract][Full Text] [Related]
4. [MAM-E17 schizophrenia rat model].
Kállai V; Tóth A; Gálosi R; Szabó I; Petykó Z; Karádi Z; Kállai J; Lénárd L
Psychiatr Hung; 2015; 30(1):4-17. PubMed ID: 25867884
[TBL] [Abstract][Full Text] [Related]
5. Hypofrontality and Posterior Hyperactivity in Early Schizophrenia: Imaging and Behavior in a Preclinical Model.
Kaneko G; Sanganahalli BG; Groman SM; Wang H; Coman D; Rao J; Herman P; Jiang L; Rich K; de Graaf RA; Taylor JR; Hyder F
Biol Psychiatry; 2017 Mar; 81(6):503-513. PubMed ID: 27450031
[TBL] [Abstract][Full Text] [Related]
6. Neural basis of psychosis-related behaviour in the infection model of schizophrenia.
Meyer U; Feldon J
Behav Brain Res; 2009 Dec; 204(2):322-34. PubMed ID: 19154759
[TBL] [Abstract][Full Text] [Related]
7. The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia.
Tseng KY; Chambers RA; Lipska BK
Behav Brain Res; 2009 Dec; 204(2):295-305. PubMed ID: 19100784
[TBL] [Abstract][Full Text] [Related]
8. Evaluating negative-symptom-like behavioural changes in developmental models of schizophrenia.
Moser P
Eur Neuropsychopharmacol; 2014 May; 24(5):774-87. PubMed ID: 24332891
[TBL] [Abstract][Full Text] [Related]
9. Postnatal Phencyclidine (PCP) as a Neurodevelopmental Animal Model of Schizophrenia Pathophysiology and Symptomatology: A Review.
Grayson B; Barnes SA; Markou A; Piercy C; Podda G; Neill JC
Curr Top Behav Neurosci; 2016; 29():403-428. PubMed ID: 26510740
[TBL] [Abstract][Full Text] [Related]
10. A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia.
Moore H; Jentsch JD; Ghajarnia M; Geyer MA; Grace AA
Biol Psychiatry; 2006 Aug; 60(3):253-64. PubMed ID: 16581031
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia.
Vuillermot S; Weber L; Feldon J; Meyer U
J Neurosci; 2010 Jan; 30(4):1270-87. PubMed ID: 20107055
[TBL] [Abstract][Full Text] [Related]
12. Adolescent Social Isolation Affects Schizophrenia-Like Behavior in the MAM-E17 Model of Schizophrenia.
Bator E; Latusz J; Głowacka U; Radaszkiewicz A; Mudlaff K; Maćkowiak M
Neurotox Res; 2018 Aug; 34(2):305-323. PubMed ID: 29536265
[TBL] [Abstract][Full Text] [Related]
13. Schizophrenia: do all roads lead to dopamine or is this where they start? Evidence from two epidemiologically informed developmental rodent models.
Eyles D; Feldon J; Meyer U
Transl Psychiatry; 2012 Feb; 2(2):e81. PubMed ID: 22832818
[TBL] [Abstract][Full Text] [Related]
14. Enhanced hippocampal neuronal excitability and LTP persistence associated with reduced behavioral flexibility in the maternal immune activation model of schizophrenia.
Savanthrapadian S; Wolff AR; Logan BJ; Eckert MJ; Bilkey DK; Abraham WC
Hippocampus; 2013 Dec; 23(12):1395-409. PubMed ID: 23966340
[TBL] [Abstract][Full Text] [Related]
15. The risk for behavioural deficits is determined by the maternal immune response to prenatal immune challenge in a neurodevelopmental model.
Missault S; Van den Eynde K; Vanden Berghe W; Fransen E; Weeren A; Timmermans JP; Kumar-Singh S; Dedeurwaerdere S
Brain Behav Immun; 2014 Nov; 42():138-46. PubMed ID: 24973728
[TBL] [Abstract][Full Text] [Related]
16. Post-weaning social isolation of rats leads to long-term disruption of the gut microbiota-immune-brain axis.
Dunphy-Doherty F; O'Mahony SM; Peterson VL; O'Sullivan O; Crispie F; Cotter PD; Wigmore P; King MV; Cryan JF; Fone KCF
Brain Behav Immun; 2018 Feb; 68():261-273. PubMed ID: 29104061
[TBL] [Abstract][Full Text] [Related]
17. Prenatal treatment with methylazoxymethanol acetate as a neurodevelopmental disruption model of schizophrenia in mice.
Takahashi K; Nakagawasai O; Sakuma W; Nemoto W; Odaira T; Lin JR; Onogi H; Srivastava LK; Tan-No K
Neuropharmacology; 2019 May; 150():1-14. PubMed ID: 30831160
[TBL] [Abstract][Full Text] [Related]
18. Cognitive performance of the MAM-E17 schizophrenia model rats in different age-periods.
Kállai V; Lénárd L; Péczely L; Gálosi R; Dusa D; Tóth A; László K; Kertes E; Kovács A; Zagoracz O; Berta B; Karádi Z; Ollmann T
Behav Brain Res; 2020 Feb; 379():112345. PubMed ID: 31704232
[TBL] [Abstract][Full Text] [Related]
19. Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia.
Gomes FV; Guimarães FS; Grace AA
Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522381
[TBL] [Abstract][Full Text] [Related]
20. Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model.
Li Q; Cheung C; Wei R; Hui ES; Feldon J; Meyer U; Chung S; Chua SE; Sham PC; Wu EX; McAlonan GM
PLoS One; 2009 Jul; 4(7):e6354. PubMed ID: 19629183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
